CORRELATION BETWEEN TUMOR VOLUME DOUBLING TIME AND HISTOLOGIC-FINDINGS IN GASTRIC SMOOTH-MUSCLE TUMORS - CLINICAL IMPLICATIONS OF TUMOR VOLUME DOUBLING TIME

被引:11
|
作者
UEYAMA, T
KAWAMOTO, K
IWASHITA, I
MASUDA, K
HARAGUCHI, Y
OIWA, T
YOSHIDA, M
UTSUNOMIYA, T
机构
[1] SAWARA HOSP,DIV GASTROENTEROL,FUKUOKA,JAPAN
[2] OIWA GASTROINTESTINAL HOSP,FUKUOKA,JAPAN
[3] MUNAKATA ISHIKAI HOSP,DIV RADIOL,FUKUOKA,JAPAN
[4] KYUSHU UNIV,FAC MED,DEPT PATHOL 2,FUKUOKA,JAPAN
关键词
X-RAY; GROWTH RATE; MITOTIC RATE; STOMACH; LEIOMYOMA; LEIOMYOSARCOMA;
D O I
10.1002/jso.2930600104
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To assess the clinical implications of the tumor volume doubling time of gastric smooth muscle tumors based on a comparison with the histologic findings, seven tumors (four leiomyomas and three leiomyosarcomas) were followed up by consecutive upper gastrointestinal studies between March 1985 and December 1993. The patients were four men and three women with an average age of 58 years (range: 50-71 years). The observation period ranged from 6 to 51 months, with an average of 35 months. All tumors were surgically resected and the histologic diagnosis was confirmed. The following microscopic features were evaluated: 1) mitotic rate, 2) nuclear atypia, and 3) cellularity. Each tumor was also evaluated for the presence or absence of necrosis, hemorrhage, and degeneration. The doubling time ranged from 5 to 27 months with a mean of 16 months. There was a strong negative correlation between the mitotic rate and the doubling time (r = -0.935, P = 0.0019). The doubling time was also significantly related to nuclear atypia, but the number of tumors studied was so small that its reliability was questionable. The doubling time was not related to any other histologic findings. This study shows that the doubling time is useful for estimating the malignant potential of gastric smooth muscle tumors, and that tumors with a doubling time of 16 months or less should be considered as malignant. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:12 / 17
页数:6
相关论文
共 50 条
  • [21] Prognostic value of tumor volume doubling time in lung-metastatic adenoid cystic carcinoma
    Lago, Eduardo A. Dal
    Yang, Zixi
    Hoff, Camilla O.
    Bonini, Flavia
    Sawyer, Matthew
    Wang, Kaiwen
    Lewis, Whitney
    Wahid, Kareem A.
    Hanna, Ehab Y.
    El-Naggar, Adel
    Fuller, Clifton D.
    Kundu, Suprateek
    Godoy, Myrna
    Ferrarotto, Renata
    ORAL ONCOLOGY, 2024, 151
  • [22] Breast Cancer Growth on Serial MRI: Volume Doubling Time Based on 3-Dimensional Tumor Volume Assessment
    Wang, Lijun
    Luo, Ran
    Chen, Yanhong
    Liu, Huanhuan
    Guan, Wenbin
    Li, Rui
    Zhang, Zhengwei
    Duan, Shaofeng
    Wang, Dengbin
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2023, 58 (04) : 1303 - 1313
  • [23] CLINICAL USEFULNESS OF TRANSABDOMINAL ULTRASONOGRAPHY FOR DIAGNOSIS AND FOLLOW-UP OF GASTRIC SUBMUCOSAL TUMORS: CLINICAL IMPLICATION OF THE TUMOR DOUBLING TIME
    Manabe, Noriaki
    Ayaki, Maki
    Katsumata, Ryo
    Fujita, Minoru
    Haruma, Ken
    GASTROINTESTINAL ENDOSCOPY, 2022, 95 (06) : AB486 - AB487
  • [24] Prognostic impact of the tumor volume doubling time in clinical T1 non-small cell lung cancer with solid radiological findings
    Nakahashi, Kenta
    Shiono, Satoshi
    Nakatsuka, Marina
    Endo, Makoto
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 126 (07) : 1330 - 1340
  • [25] Editorial for "Breast Cancer Growth on Serial MRI: Volume Doubling Time Based on 3-Dimensional Tumor Volume Assessment"
    Pineda, Federico D.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2023, 58 (04) : 1314 - 1314
  • [26] Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea
    Jin, Meihua
    Kim, Hye In
    Ha, Jeonghoon
    Jeon, Min Ji
    Kim, Won Gu
    Lim, Dong-Jun
    Kim, Tae Yong
    Chung, Jae Hoon
    Shong, Young Kee
    Kim, Tae Hyuk
    Kim, Won Bae
    THYROID, 2021, 31 (10) : 1494 - 1501
  • [27] Volume doubling time and radiomic features predict tumor behavior of screen-detected lung cancers
    Perez-Morales, Jaileene
    Lu, Hong
    Mu, Wei
    Tunali, Ilke
    Kutuk, Tugce
    Eschrich, Steven A.
    Balagurunathan, Yoganand
    Gillies, Robert J.
    Schabath, Matthew B.
    CANCER BIOMARKERS, 2022, 33 (04) : 489 - 501
  • [28] FOLLOW-UP EXAMINATION SCHEDULE OF POSTOPERATIVE HCC PATIENTS BASED ON TUMOR VOLUME DOUBLING TIME
    OKADA, S
    OKAZAKI, N
    NOSE, H
    AOKI, K
    KAWANO, N
    YAMAMOTO, J
    SHIMADA, K
    TAKAYAMA, T
    KOSUGE, T
    YAMASAKI, S
    HEPATO-GASTROENTEROLOGY, 1993, 40 (04) : 311 - 315
  • [29] Prognostic Value of Time To Progression vs. Tumor Volume Doubling Time in Patients with Adenoid Cystic Carcinoma Metastatic To The Lung
    Sousa, L. G.
    Dal Lago, E. Andreazza
    Yang, Z.
    Hoff, C. O.
    Bonini, F.
    Sawyer, M.
    Wang, K.
    Lewis, W.
    Wahid, K. A.
    Hanna, E. Y.
    El-Naggar, A. K.
    Fuller, C. D.
    Kundu, S.
    Godoy, M.
    Ferrarotto, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E80 - E81
  • [30] CORRELATION OF VASCULAR SMOOTH-MUSCLE CELL (VSMC) CULTURE DOUBLING TIME WITH THE DEGREE OF DIABETES-MELLITUS (DM) IN THE RABBIT
    ZHANG, X
    ALIPUI, C
    LEE, JR
    SALCIDOSANCHEZ, FJ
    TENNER, TE
    FASEB JOURNAL, 1995, 9 (03): : A610 - A610